Aurinia Pharm Ord
(AUPH)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -15,478 | -70,792 | -67,460 | -54,340 | -51,941 |
| Depreciation Amortization | 369 | 1,338 | 1,007 | 674 | 333 |
| Accounts receivable | -116 | -23 | -329 | -199 | -37 |
| Other Working Capital | -4,108 | 1,699 | -284 | -3,734 | -249 |
| Other Operating Activity | 4,953 | 26,609 | 34,828 | 33,886 | 42,179 |
| Operating Cash Flow | $-14,380 | $-41,169 | $-32,238 | $-23,713 | $-9,715 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -20,000 | -7,978 | -94,946 | -10,057 | -3,044 |
| PPE Investments | -22 | -25 | -16 | -16 | -4 |
| Investing Cash Flow | $-20,022 | $-8,003 | $-94,962 | $-10,073 | $-3,048 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | 166,468 | 166,413 | 165,170 | 163,515 |
| Other Financing Activity | 0 | 8,684 | 8,684 | 8,684 | 8,665 |
| Financing Cash Flow | $N/A | $175,152 | $175,097 | $173,854 | $172,180 |
| Beginning Cash Position | 165,629 | 39,649 | 39,649 | 39,649 | 39,649 |
| End Cash Position | 131,227 | 165,629 | 87,546 | 179,717 | 199,066 |
| Net Cash Flow | $-34,402 | $125,980 | $47,897 | $140,068 | $159,417 |
| Free Cash Flow | |||||
| Operating Cash Flow | -14,380 | -41,169 | -32,238 | -23,713 | -9,715 |
| Capital Expenditure | -22 | -25 | -16 | -16 | -4 |
| Free Cash Flow | -14,402 | -41,194 | -32,254 | -23,729 | -9,719 |